CDX CardieX Announces Expansion of Bayer Pharma Trial Contract 06/03/19 PRICE SENSITIVE Share CDX Appendix 4D Half Year Report 28/02/19 PRICE SENSITIVE Share CDX Half Year Accounts 28/02/19 PRICE SENSITIVE Share CDX CardieX Update on the Acquisition of 50.5% of inHealth 01/02/19 PRICE SENSITIVE Share CDX Convertible Note Application Received from C2 Ventures 22/01/19 PRICE SENSITIVE Share CDX Response to ASX Aware Query 18/01/19 PRICE SENSITIVE Share CDX Cardiex's inHealth Executes Major Co-Marketing Agreement 15/01/19 PRICE SENSITIVE Share CDX CardieX's inHealth Signs LOI With Global Electronics Company 18/12/18 PRICE SENSITIVE Share CDX CardieX Signs Agreement for Wearable Sensor Development 12/12/18 PRICE SENSITIVE Share CDX CardieX Successfully Closes Oversubscribed $5.5m Fundraising 06/12/18 PRICE SENSITIVE Share CDX Trading Halt 04/12/18 PRICE SENSITIVE Share CDX Pause in Trading 04/12/18 PRICE SENSITIVE Share CDX CEO Strategy Overview and 2019 Plan 03/12/18 PRICE SENSITIVE Share CDX CardieX Owned inHealth Partners with Kaiser Permanente 28/11/18 PRICE SENSITIVE Share CDX CardieX Corporate Update & Overview of inHealth Transaction 12/11/18 PRICE SENSITIVE Share CDX CardieX Partner Blumio Initiates Large Scale Clinical Trial 01/11/18 PRICE SENSITIVE Share CDX New Medical Devices Supply Contract with AstraZeneca 26/10/18 PRICE SENSITIVE Share CDX CardieX Subsidiary Wins New Medical Devices Supply Contract 26/10/18 PRICE SENSITIVE Share CDX Acquisition of Major Stake in inHealth Medical 16/10/18 PRICE SENSITIVE Share CDX Trading Halt 12/10/18 PRICE SENSITIVE Share CDX Receipt of Subscription Proceeds from C2 Ventures Pty Ltd 11/10/18 PRICE SENSITIVE Share CDX CardieX Appendix 4E and 2018 Annual Financial Statements 31/08/18 PRICE SENSITIVE Share CDX CardieX Reports Successful Trial Results for Wearable Sensor 24/07/18 PRICE SENSITIVE download Created with Sketch. 160.25KB Share CDX CardieX Makes First Investment in Wearable Tech Partnership 19/06/18 PRICE SENSITIVE download Created with Sketch. 182.12KB Share CDX CardieX (AtCor) Entitlements Issue Heavily Over Subscribed 12/06/18 PRICE SENSITIVE download Created with Sketch. 155.68KB Share CDX AtCor Announces Wearable Trial with Macquarie University 21/05/18 PRICE SENSITIVE Share CDX Blumio Wearable Cardio Trial with Macquarie University 21/05/18 PRICE SENSITIVE Share CDX Underwritten Rights Issue Prospectus Lodged with ASIC 23/04/18 PRICE SENSITIVE Share CDX Oversubscribed Capital Raising to Fast Track New Strategy 23/04/18 PRICE SENSITIVE Share CDX Trading Halt 19/04/18 PRICE SENSITIVE Share CDX AtCor Announces First Steps in Major Strategic Repositioning 14/03/18 PRICE SENSITIVE Share CDX Half Yearly Report and Accounts 28/02/18 PRICE SENSITIVE Share CDX AtCor's XCEL device clinically validated in 3rd party study 23/01/18 PRICE SENSITIVE Share CDX AtCor and PhysioAge Systems announce supply agreement 11/01/18 PRICE SENSITIVE Share CDX AtCor secures $1.0 million new pharmaceutical trial contract 15/12/17 PRICE SENSITIVE Share CDX AtCor appoints Craig Cooper as CEO 30/11/17 PRICE SENSITIVE Share CDX Chairman's address to 2017 AGM 30/11/17 PRICE SENSITIVE Share CDX Tax Refund 30/10/17 PRICE SENSITIVE Share CDX Security Purchase Plan 08/09/17 PRICE SENSITIVE Share CDX Full Year Statutory Accounts 31/08/17 PRICE SENSITIVE Share CDX Share Purchase Plan 29/08/17 PRICE SENSITIVE Share CDX Share Placement 08/08/17 PRICE SENSITIVE Share CDX Trading Halt 04/08/17 PRICE SENSITIVE Share CDX AtCor restructures operations 02/08/17 PRICE SENSITIVE Share CDX AtCor Signs New Agreement 31/07/17 PRICE SENSITIVE Share CDX Secures $0.8 million new pharmaceutical trials contracts 12/07/17 PRICE SENSITIVE Share CDX AtCor Signs New Network Health Systems Agreement 07/06/17 PRICE SENSITIVE Share CDX Business update and Strategic Review 18/05/17 PRICE SENSITIVE Share CDX Half Yearly Report and Accounts 24/02/17 PRICE SENSITIVE Share CDX AtCor Signs Local Health System Agreement 23/02/17 PRICE SENSITIVE Share CDX Study Finds Central Aortic Waveform Improves HF Treatment 16/02/17 PRICE SENSITIVE Share CDX Tax refund 14/02/17 PRICE SENSITIVE Share CDX Positive Novartis drug trial using SphygmoCor XCEL 23/01/17 PRICE SENSITIVE Share CDX AtCor completes share placement 16/11/16 PRICE SENSITIVE Share CDX Trading Halt 14/11/16 PRICE SENSITIVE Share CDX Leading research team highlights role of SphygmoCor 04/11/16 PRICE SENSITIVE Share CDX FY2016 results-ACG.AX 30/08/16 PRICE SENSITIVE Share CDX Full Year Statutory Accounts-ACG.AX 30/08/16 PRICE SENSITIVE Share CDX Large national plan to reimburse SphygmoCor test-ACG.AX 07/07/16 PRICE SENSITIVE Share CDX $0.6 million pharmaceutical trial extension-ACG.AX 29/06/16 PRICE SENSITIVE Share CDX Tax refund 14/03/16 PRICE SENSITIVE Share CDX Patent granted in USA 09/03/16 PRICE SENSITIVE Share CDX FDA clearance for Oscar 2 with SphygmoCor inside 03/03/16 PRICE SENSITIVE Share CDX CPT-1 Reimbursement Update 29/02/16 PRICE SENSITIVE Share CDX Patent granted in Japan 17/02/16 PRICE SENSITIVE Share CDX Half Yearly Report and Accounts 12/02/16 PRICE SENSITIVE Share CDX US$0.6m new pharmaceutical trial contract 05/02/16 PRICE SENSITIVE Share CDX Market update 08/01/16 PRICE SENSITIVE Share CDX AtCor and A&D sign multiyear distribution contract for Japan 16/12/15 PRICE SENSITIVE Share CDX US Medicare payment for new category 1 code announced 02/11/15 PRICE SENSITIVE Share CDX App 4E / Full Year Statutory Accounts 20/08/15 PRICE SENSITIVE Share CDX Rights offer booklet 01/07/15 PRICE SENSITIVE Share CDX Successful share placement and rights issue 17/06/15 PRICE SENSITIVE Share CDX Trading Halt 15/06/15 PRICE SENSITIVE Share CDX Expert panel guidelines for central waveform analysis 28/05/15 PRICE SENSITIVE Share CDX CE Mark for Oscar 2 with SphygmoCor Inside 04/05/15 PRICE SENSITIVE Share CDX AMA accepts recommendation for category 1 CPT code 10/03/15 PRICE SENSITIVE Share CDX Half Yearly Report and Accounts 23/02/15 PRICE SENSITIVE Share CDX Tax refund 22/01/15 PRICE SENSITIVE Share CDX Successful share placement 28/11/14 PRICE SENSITIVE Share CDX Trading Halt 27/11/14 PRICE SENSITIVE Share CDX SphygmoCor selected for US publicly funded study 07/10/14 PRICE SENSITIVE Share CDX SphygmoCor selected for French Alzheimers trial 03/09/14 PRICE SENSITIVE Share CDX App 4E / Full Year Statutory Accounts 28/08/14 PRICE SENSITIVE Share CDX Market update 03/07/14 PRICE SENSITIVE Share CDX AtCor and SunTech launch innovative ABPM for Central BP 18/06/14 PRICE SENSITIVE Share CDX First SphygmoCor sales in China 02/06/14 PRICE SENSITIVE Share CDX Patent grant in USA 16/04/14 PRICE SENSITIVE Share CDX Study shows improved outcomes from SphygmoCor guided therapy 03/04/14 PRICE SENSITIVE Share CDX Half Yearly Report and Accounts 20/02/14 PRICE SENSITIVE Share CDX SphygmoCor XCEL approved for sale in Canada 30/01/14 PRICE SENSITIVE Share CDX SphygmoCor XCEL approved for sale in China 14/01/14 PRICE SENSITIVE Share CDX Market update 09/01/14 PRICE SENSITIVE Share CDX ASX Price Query & Response 12/11/13 PRICE SENSITIVE Share CDX US$0.6 million new pharmaceutical trial contract 28/10/13 PRICE SENSITIVE Share CDX Appendix 4C - quarterly 23/10/13 PRICE SENSITIVE Share CDX Aust study demonstrates the benefits of measuring central BP 26/09/13 PRICE SENSITIVE Share CDX SphygmoCor XCEL approved for sale in Mexico 04/09/13 PRICE SENSITIVE Share CDX Preliminary Final Report & Annual Accounts 30/08/13 PRICE SENSITIVE Share CDX Half Yearly Report and Accounts 30/08/13 PRICE SENSITIVE Share
(20min delay)
